2.84
price down icon7.19%   -0.22
pre-market  Pre-market:  3.00   0.16   +5.63%
loading

Grace Therapeutics Inc Stock (GRCE) Latest News

pulisher
Feb 25, 2025

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Can Grace Therapeutics' Novel aSAH Treatment Impress Investors at Major Healthcare Conference? - StockTitan

Feb 25, 2025
pulisher
Feb 22, 2025

Grace Therapeutics reports positive Phase 3 trial results for GTx-104 - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Grace Therapeutics secures up to $30 million financing - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

GRCE: STRIVE-ON Results Reported - MSN

Feb 21, 2025
pulisher
Feb 19, 2025

Corcept Therapeutics stock soars to all-time high of $62.34 - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Grace Therapeutics’ (GRCE) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

H.C. Wainwright reiterates buy on Grace Therapeutics stock By Investing.com - Investing.com Australia

Feb 18, 2025
pulisher
Feb 18, 2025

H.C. Wainwright reiterates buy on Grace Therapeutics stock - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating - TipRanks

Feb 18, 2025
pulisher
Feb 14, 2025

Grace Therapeutics On Track For NDA Submission Of GTx-104 For Aneurysmal Subarachnoid Hemorrhage - Nasdaq

Feb 14, 2025
pulisher
Feb 13, 2025

GRACE THERAPEUTICS Earnings Results: $GRCE Reports Quarterly Earnings - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update - The Manila Times

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Therapeutics Reports Positive Phase 3 STRIVE-ON Trial Results for GTx-104 and Secures $30 Million in Financing; NDA Submission Expected by Mid-2025 - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Therapeutics Inc. (GRCE) reports earnings - Quartz

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results - TradingView

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Reports Clinical Trial Victory and Major Cash Infusion in Latest Earnings - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Grace Therapeutics, Inc. SEC 10-Q Report - TradingView

Feb 13, 2025
pulisher
Feb 12, 2025

Grace Therapeutics secures up to $30 million financing By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Grace Therapeutics secures $15m for GTx-104 pre-commercial development - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Grace therapeutics announces private placement financing of $30 million - MSN

Feb 11, 2025
pulisher
Feb 10, 2025

Sector Update: Health Care Stocks Softer Late Afternoon -February 10, 2025 at 04:01 pm EST - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Sector Update: Health Care Stocks Softer Late Afternoon - TradingView

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Shares Rise After Private Placement Financing of up to $30 Million - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study - Benzinga

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Announces Financing of $30 Million - citybiz

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics meets main goal in late stage trial for its aneurysmal SAH treatment - Seeking Alpha

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Phase 3 STRIVE-ON Safety Study Meets Primary Goal - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics reports positive Phase 3 trial results for GTx-104 By Investing.com - Investing.com South Africa

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH - The Manila Times

Feb 10, 2025
pulisher
Feb 10, 2025

We're (SUPER) Sorry for your Team's Loss: Vivid Seats and The Bouqs Co. Launch Consolation Contest - The Manila Times

Feb 10, 2025
pulisher
Feb 10, 2025

Nasdaq, Inc. Announces Cash Tender Offers for Up to $200 Million Outstanding Debt Securities - The Manila Times

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Secures Up to $30 Million in Financing Led by Nantahala Capital and ADAR1 Partners for GTx-104 Development - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

Grace Therapeutics Lands Strategic $30M Financing Deal: Major Boost for Critical Brain Hemorrhage Treatment - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

Grace's GTx-104 Clinical Data Reveals Major Breakthrough for Brain Hemorrhage Treatment - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

Converge Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Conference Call Details - Yahoo Canada Finance

Feb 10, 2025
pulisher
Feb 08, 2025

Grace Therapeutics (GRCE) to Release Quarterly Earnings on Monday - Defense World

Feb 08, 2025
pulisher
Feb 05, 2025

GraceKennedy buys full ownership of Catherine’s Peak Bottling Company - Yahoo

Feb 05, 2025
pulisher
Feb 04, 2025

MaRS appoints Grace Lee Reynolds as CEO and welcomes new leaders to the board - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

Corcept Therapeutics stock soars to all-time high of $70.78 - MSN

Feb 03, 2025
pulisher
Jan 31, 2025

University President Mourns Student Who Died in Midair Collision - Yahoo Finance

Jan 31, 2025
pulisher
Jan 31, 2025

The Orlando Credit Union Charitable Foundation Opens Applications for 2025 Grace Chewning Scholarship Fund - Yahoo Finance

Jan 31, 2025
pulisher
Jan 30, 2025

Snowflake CEO: DeepSeek is the real deal, and other OpenAI rivals are coming - Yahoo Finance

Jan 30, 2025
pulisher
Jan 28, 2025

Viracta Therapeutics strikes deal to avoid default - MSN

Jan 28, 2025
pulisher
Jan 23, 2025

3 US Penny Stocks With Market Cap Under $70M - Simply Wall St

Jan 23, 2025
pulisher
Jan 23, 2025

Nav Welcomes Grace Liu as Chief Financial Officer - Yahoo Finance

Jan 23, 2025
pulisher
Jan 21, 2025

HEAVY.AI Announces Availability of Analytics Platform Accelerated by NVIDIA Grace Hopper Superchip - Yahoo Finance

Jan 21, 2025
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):